Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus

NCT05779644 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Metformin
Obesity, Abdominal
Diabetes Mellitus, Type 2
Abdominal Fat
Non-Alcoholic Fatty Liver Disease
Metabolism Disorder, Glucose
Metabolism Disorder, Lipid

Interventions

DRUG: Liraglutide
DRUG: Semaglutide
DRUG: Metformin

Sponsor

RenJi Hospital